Drug Shortage Report for MAXALT RPD
Report ID | 145497 |
Drug Identification Number | 02240518 |
Brand name | MAXALT RPD |
Common or Proper name | rizatriptan benzoate wafers |
Company Name | ORGANON CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | RIZATRIPTAN |
Strength(s) | 5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL ORAL |
Packaging size | 12 |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2021-09-17 |
Actual start date | 2021-09-16 |
Estimated end date | 2021-09-29 |
Actual end date | 2021-09-29 |
Shortage status | Resolved |
Updated date | 2021-09-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-844-820-5468 dpoc.canada@organon.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2021-09-30 | English | Compare |
v9 | 2021-09-29 | French | Compare |
v8 | 2021-09-29 | English | Compare |
v7 | 2021-09-23 | English | Compare |
v6 | 2021-09-21 | English | Compare |
v5 | 2021-09-17 | English | Compare |
v4 | 2021-09-16 | French | Compare |
v3 | 2021-09-16 | English | Compare |
v2 | 2021-09-10 | French | Compare |
v1 | 2021-09-10 | English | Compare |
Showing 1 to 10 of 10